Idiopathic Pulmonary Fibrosis: Phenotypes and Comorbidities
Section snippets
Are there distinct phenotypes in IPF?
A phenotype is the outward manifestation of a gene or genes, may involve more than one organ system, and is dynamic, changing over time or in response to the environment.2 In contrast, genotypes are stable over the life span of an individual. Defining a phenotype concisely and accurately is crucial, as phenotypes are used to predict prognosis, select patients for enrollment into clinical trials, and provide the foundation for studies exploring the pathobiology of disease. Some investigators
Gastroeosophageal Reflux Disease
Evidence that gastroeosophageal reflux disease (GERD) is associated with IPF and recurrent silent aspiration of gastric acid is associated with acute exacerbations of IPF makes GERD an attractive hypothesis for the etiology of IPF.27, 28 Instillation of acid into the tracheobronchial tree produces pulmonary fibrosis in animal models29, 30 and aspiration of gastric contents can cause pulmonary fibrosis in humans.31
The prevalence of GERD in IPF is estimated to be between 66% and 87%.28, 32, 33
Summary
Patients with IPF face progressive dyspnea and disability, poor prognosis, and limited treatment options. Once thought to be a slowly progressive disease, IPF may have an accelerated variant phenotype. Combined pulmonary fibrosis and emphysema and disproportionate pulmonary hypertension in IPF may also be distinct phenotypes; further investigation is needed to characterize these phenotypes and determine if there is a plausible biologic explanation for these entities. Identification and
References (64)
- et al.
Idiopathic pulmonary fibrosis
Lancet
(2011) - et al.
The syndrome of combined pulmonary fibrosis and emphysema
Chest
(2009) - et al.
Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension
Chest
(2009) - et al.
Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment
Respir Med
(1990) - et al.
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
Chest
(2006) - et al.
The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis
Chest
(2005) - et al.
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
Chest
(2007) - et al.
Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis
Am J Transplant
(2006) - et al.
Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis
Chest
(2007) - et al.
Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines
Chest
(2007)
Sildenafil improves walk distance in idiopathic pulmonary fibrosis∗
Chest
Aspiration pneumonitis—the sequelae
Chest
Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation
J Thorac Cardiovasc Surg
Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series
Chest
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation
J Thorac Cardiovasc Surg
Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis
Chest
Assessment of health-related quality of life in patients with interstitial lung disease
Chest
Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests
Eur J Intern Med
Gender influences health-related quality of life in IPF
Respir Med
Depression and functional status are strongly associated with dyspnea in interstitial lung disease
Chest
Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping
Hum Hered
Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern
PLoS One
Pulmonary hypertension in idiopathic pulmonary fibrosis: a review
Sarcoidosis Vasc Diffuse Lung Dis
Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis
Am J Respir Crit Care Med
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Eur Respir J
Cryptogenic fibrosing alveolitis with preserved lung volumes
Thorax
Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds
Eur Respir J
Diagnosis and differential assessment of pulmonary arterial hypertension
J Am Coll Cardiol
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease
Am J Respir Crit Care Med
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Eur Respir J
Noninvasive estimation of clinically asymptomatic pulmonary hypertension in idiopathic pulmonary fibrosis
Indian J Chest Dis Allied Sci
Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Respiration
Cited by (40)
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version
2023, Respiratory Medicine and ResearchFrench practical guidelines for the diagnosis and management of IPF – 2021 update, full version
2022, Revue des Maladies RespiratoiresCluster analysis based clinical profiling of Idiopathic Pulmonary Fibrosis patients according to comorbidities evident prior to diagnosis: a single-center observational study
2020, European Journal of Internal MedicineCitation Excerpt :Contributing to the preceding studies, our study shows that disease phenotypes of IPF could be identified based on events related to comorbidities or the pulmonary fibrosis process itself occurring before IPF diagnosis, while patients are still at the early stages of disease presentation. In our ambulatory setup, we did not encounter patients whose initial presentation was acute exacerbation of IPF, though we are aware that this is a common presentation as well.[29] This study adds another dimension to understanding the clinical evolution of IPF, by defining possible profiles of patients according to comorbidities that are recognized years before diagnosis of IPF.
Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?
2018, Respiratory MedicineCitation Excerpt :Patients demonstrating combined histopathology patterns of UIP and other interstitial pneumonia in the same lung (discordant UIP pattern) are known to have clinical behavior similar to that of patients with UIP on histopathology from different lobes of the same lung (concordant UIP pattern) [14]. IPF phenotypes have been described, most well recognized is Combined Pulmonary Fibrosis and Emphysema (CPFE) which has been described as a syndrome distinct from Lone-IPF [15–17]. Similarly, there has been ongoing interest in describing sarcoidosis phenotypes [18–21].
Disclosure: Dr Fell has participated in scientific advisory boards for Actelion and InterMune.